Claims about 'stable BPC-157' (Arginine BPC-157) have become widespread. We cut through the marketing and examine what the science actually says.
What is "stable BPC-157"?
In recent years, a variant marketed as "stable BPC-157" or "Arginine BPC-157" has appeared in the research peptide market. Proponents claim it offers superior oral bioavailability and greater resistance to degradation compared to the standard form. This post examines those claims in the context of published research and explains what researchers should understand before working with either form.
BPC-157: the standard sequence
The original BPC-157 (Body Protective Compound-157) is a synthetic pentadecapeptide — a sequence of 15 amino acids derived from a naturally occurring protein in gastric juice. It has been the subject of numerous in vitro and in vivo studies examining its molecular interactions with various biological systems.
Standard BPC-157 is widely characterised in the published literature, with a well-established molecular weight of 1,419.5 g/mol and a known sequence for which authentic reference material exists.
Arginine BPC-157: the "stable" variant
The "stable" variant typically incorporates an arginine modification designed, in theory, to improve stability in low-pH environments — conditions found in the gastrointestinal tract. The marketing claim is that this modification makes it more suitable for oral research applications.
The problem with the claims
The published evidence base for Arginine BPC-157 is significantly thinner than for standard BPC-157. Most studies that are cited in marketing material for the "stable" variant refer to standard BPC-157 research, not the modified form. The direct comparison data that would be required to substantiate "superior stability" claims has, to date, not been published in peer-reviewed literature to any meaningful extent.
Researchers should be cautious about purchasing "stable BPC-157" for studies where the intended outcome depends on specific molecular interactions. Without a well-characterised reference standard for the modified form, reproducibility across labs is difficult to ensure.
Our position at My UK Peptides
We supply both forms clearly labelled with their structural designation. When ordering, always confirm which form you require for your specific research protocol. If your study is intended to replicate or build upon published BPC-157 research, standard BPC-157 remains the better-characterised option.
All peptides from My UK Peptides are supplied for research use only. Not for human or veterinary use.